BIOMAT Database Logo BIOMAT Database Logo

Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome. 1995

B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat

UI MeSH Term Description Entries
D008297 Male Males
D002809 Chondroitin Sulfates Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate. Chondroitin 4-Sulfate,Chondroitin 6-Sulfate,Chondroitin Sulfate A,Chondroitin Sulfate C,Blutal,Chondroitin 4-Sulfate, Aluminum Salt,Chondroitin 4-Sulfate, Potassium Salt,Chondroitin 6-Sulfate, Potassium Salt,Chondroitin 6-Sulfate, Sodium Salt,Chondroitin Sulfate,Chondroitin Sulfate 4-Sulfate, Sodium Salt,Chondroitin Sulfate, Calcium Salt,Chondroitin Sulfate, Iron (+3) Salt,Chondroitin Sulfate, Iron Salt,Chondroitin Sulfate, Potassium Salt,Chondroitin Sulfate, Sodium Salt,Chondroitin Sulfate, Zinc Salt,Chonsurid,Sodium Chondroitin Sulfate,Translagen,Chondroitin 4 Sulfate,Chondroitin 4 Sulfate, Aluminum Salt,Chondroitin 4 Sulfate, Potassium Salt,Chondroitin 6 Sulfate,Chondroitin 6 Sulfate, Potassium Salt,Chondroitin 6 Sulfate, Sodium Salt,Chondroitin Sulfate 4 Sulfate, Sodium Salt,Chondroitin Sulfate, Sodium,Sulfate, Chondroitin,Sulfate, Sodium Chondroitin,Sulfates, Chondroitin
D003871 Dermatan Sulfate A naturally occurring glycosaminoglycan found mostly in the skin and in connective tissue. It differs from CHONDROITIN SULFATE A (see CHONDROITIN SULFATES) by containing IDURONIC ACID in place of glucuronic acid, its epimer, at carbon atom 5. (from Merck, 12th ed) Chondroitin Sulfate B,beta-Heparin,Sulfate B, Chondroitin,Sulfate, Dermatan,beta Heparin
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006497 Heparitin Sulfate A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS. Heparan Sulfate,Sulfate, Heparan,Sulfate, Heparitin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D017211 Treatment Failure A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series. Failure, Treatment,Failures, Treatment,Treatment Failures

Related Publications

B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat
Orgaran in heparin-induced thrombocytopenia.
January 1992, Haemostasis,
B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat
[Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia].
January 1998, Annales francaises d'anesthesie et de reanimation,
B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat
Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).
September 1999, The Annals of thoracic surgery,
B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat
Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II.
July 2001, Acta paediatrica (Oslo, Norway : 1992),
B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat
Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.
November 1998, Catheterization and cardiovascular diagnosis,
B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat
The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations.
June 1997, Clinical and laboratory haematology,
B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat
[Successful Management of Cardiopulmonary Bypass Using Heparin in a Patient with Previous History of Heparin-induced Thrombocytopenia].
April 2015, Masui. The Japanese journal of anesthesiology,
B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat
Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172)
October 1993, Thrombosis and haemostasis,
B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat
Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
April 2008, Thrombosis and haemostasis,
B Tardy/Poncet, and P Mahul, and A M Beraud, and J P Favre, and B Tardy, and D Guyotat
Rapid-onset heparin-induced thrombocytopenia without previous heparin exposure.
January 2012, Platelets,
Copied contents to your clipboard!